1. Home
  2. TME vs PEN Comparison

TME vs PEN Comparison

Compare TME & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tencent Music Entertainment Group each representing two

TME

Tencent Music Entertainment Group each representing two

HOLD

Current Price

$8.48

Market Cap

13.9B

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$322.32

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TME
PEN
Founded
N/A
2004
Country
China
United States
Employees
5353
N/A
Industry
Broadcasting
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9B
12.8B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TME
PEN
Price
$8.48
$322.32
Analyst Decision
Buy
Hold
Analyst Count
8
16
Target Price
$19.44
$360.14
AVG Volume (30 Days)
8.1M
449.9K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
1155.56
EPS
N/A
0.82
Revenue
N/A
$1,403,665,000.00
Revenue This Year
$10.73
$14.34
Revenue Next Year
$10.19
$13.71
P/E Ratio
$15.69
$393.91
Revenue Growth
N/A
17.50
52 Week Low
$8.60
$221.26
52 Week High
$26.70
$362.41

Technical Indicators

Market Signals
Indicator
TME
PEN
Relative Strength Index (RSI) 30.00 36.07
Support Level N/A $302.19
Resistance Level $10.25 $335.61
Average True Range (ATR) 0.33 2.21
MACD 0.01 -0.06
Stochastic Oscillator 4.07 12.24

Price Performance

Historical Comparison
TME
PEN

About TME Tencent Music Entertainment Group each representing two

Tencent Music is the largest online music streaming platform in China, established in 2016 through the merger of QQ Music, Kuwo Music, and Kugou Music. Tencent, its largest shareholder, holds over 50% of the shares and more than 90% of the voting rights. Beyond streaming services, Tencent Music generates revenue through a diverse range of offerings, including podcasts, livestreaming, concerts, and karaoke.

About PEN Penumbra Inc.

Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.

Share on Social Networks: